- ISO 17025 lab-tested
- Research use only
Retatrutide Pills 3mg
-
Processed as soon as payment clears
Packed and dispatched without delay.
-
Free shipping over €99.00 to most EU countries
-
Shipment protection included
Lost or damaged in transit? We send a replacement.
-
Discreet packaging
Plain parcel, no product names on the outside.
-
We accept
Secure checkout
- SEPA bank transfer
Independent lab results
Tested before it reaches your bench
Every batch is analysed by an independent, ISO 17025-accredited laboratory before release. The report shown here belongs to the batch now shipping, so what you read is what you receive.
Janoshik Analytical
ISO/IEC 17025 accredited
- Lot
- RTPI/062026
- Tested
- June 18, 2026
- Report no.
- #171924
- Batch-specific
- Independent lab
Quality control results
-
Contaminant screen
Impurity profile
SNAC, disaccharide, retatrutide and degradation products identified; no significant contamination detected
Reported
Tests in our panel
- Visual inspection · Colour, form and integrity of the lyophilised powder and the vial seal, checked against the specification.
- Reversed-phase HPLC · Share of the sample that is the target peptide, after separating it from related impurities.
- HPLC quantitation · Milligrams of peptide actually in the vial, compared with the amount stated on the label.
- LC-MS · Confirms the molecular mass matches the expected structure of the compound.
- Elemental analysis · Screens for toxic metals that can enter through raw materials or equipment.
- Microbial culture · Checks a sample for bacterial and fungal growth.
- Endotoxin assay · Measures bacterial endotoxins, reported in endotoxin units (EU) per vial.
All published batches
Every lot of this product we have released, each with its own certificate. Newest first.
Retatrutide Pills 3mg
LatestLOT RTPI/062026
- Contaminants
- SNAC, disaccharide, retatrutide and degradation products identified; no significant contamination detected
- Tested on
- June 18, 2026
1 assay by Janoshik Analytical
Open certificate
About this compound
Retatrutide Pills 3mg - Oral Multi-Receptor Peptide for Metabolic & Weight Management Research
- Composition: Retatrutide in oral tablet form
- Category: Peptide
- Form: 30 Oral pills / tablets
- Strength: 3mg per pill
What is Retatrutide?
Retatrutide is an advanced, long-acting triple agonist peptide that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and Glucagon receptors.
It belongs to a new generation of metabolic research peptides designed to increase energy expenditure, regulate appetite, and support glucose and lipid metabolism research.
Through the simultaneous activation of multiple metabolic pathways, Retatrutide has shown remarkable potential in preclinical and clinical research investigating obesity, insulin resistance, and metabolic disorders.
Ideal for energy balance, weight regulation, and peptide-based metabolic modulation research.
Oral Retatrutide Pill Format
The oral format may be especially interesting for research models focused on bioavailability, peptide absorption, metabolic response, and long-term usability of oral peptide formulations.
Quality & Third-Party Testing
This Retatrutide Pills batch has been reviewed with independent third-party laboratory testing by Janoshik.
The available LCMS screening report identified the presence of Retatrutide together with oral formulation components including SNAC and disaccharide.
The report states that no significant contamination was detected, supporting batch transparency and quality control for research purposes.
Testing reference: Janoshik LCMS Screening, Task Number #171924, Batch RTPI/062026.
Key Research Findings
Triple Receptor Activation: Simultaneous stimulation of GLP-1, GIP, and Glucagon receptors for enhanced metabolic pathway research.
Appetite & Energy Regulation: Investigated for its influence on central mechanisms of appetite control and caloric expenditure.
Glucose & Lipid Metabolism: Studied for its role in insulin sensitivity, glucose homeostasis, and fat oxidation.
Body Composition: Researched for its potential impact on body fat reduction while supporting the preservation of lean mass.
Storage Instructions
- Store in a cool, dry place
- Protect from light and moisture
- Do not expose to high temperatures
- Keep the container tightly closed after opening
- Keep out of reach of children
Why Choose Retatrutide Pills?
Retatrutide is one of the most advanced multi-agonist peptides currently under investigation.
Through its synergistic activation of GLP-1, GIP, and Glucagon receptors, it provides unique insights into the hormonal regulation of energy balance, fat metabolism, and appetite control.
The oral pill format offers a convenient alternative to traditional vial-based peptide formulations and is especially suitable for research involving oral peptide delivery, metabolic pathway modulation, and next-generation weight management research.
Order Retatrutide Pills 3mg and explore its potential in the next generation of metabolic and weight management research.
Research notice
For laboratory research use only. This product is not a medicinal product or a food. It is not intended for human or veterinary use, or for any diagnostic or therapeutic purpose.
The buyer is responsible for receiving, storing, handling and disposing of this material safely and lawfully, in line with the rules of their country and institution. We sell only to adults aged 18 or over who are qualified to work with research materials.
Descriptions on this page summarise published research for educational purposes. They are not medical advice and make no claim about safety or effects in humans.
